Expression in plants and immunogenicity of plant virus-based experimental rabies vaccine

Vaccine

Volumn 20, Issue 25-26, 2002, Pages 3155-3164

  Yusibov, V ^a   Hooper, D C ^a   Spitsin, S V ^a   Fleysh, N ^a   Kean, R B ^a   Mikheeva, T ^a   Deka, D ^a   Karasev, A ^a   Cox, S ^a   Randall, J ^b   Koprowski, H ^a  

^a THOMAS JEFFERSON UNIVERSITY   (United States)

^b THOMAS JEFFERSON UNIVERSITY   (United States)

Author keywords

Alfalfa mosaic virus; Immunogenicity; Plant virus based vaccines

Indexed keywords

ANTIGEN; RABIES VACCINE; RECOMBINANT PROTEIN; VIRUS ANTIBODY; VIRUS PROTEIN; CAPSID PROTEIN; COAT PROTEIN, ALFALFA MOSAIC VIRUS; GLYCOPROTEIN; HYBRID PROTEIN; NUCLEOPROTEIN; RABIES VIRUS GLYCOPROTEIN (253 275); RABIES VIRUS GLYCOPROTEIN (253-275); RABIES VIRUS NUCLEOPROTEIN N (404 418); RABIES VIRUS NUCLEOPROTEIN N (404-418); RECOMBINANT VACCINE; SUBUNIT VACCINE;

ALFALFA MOSAIC VIRUS; ANTIBODY BLOOD LEVEL; ANTIBODY RESPONSE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG RESPONSE; DRUG SCREENING; GENE EXPRESSION SYSTEM; HUMAN; HUMAN EXPERIMENT; NORMAL HUMAN; PLANT LEAF; PRIORITY JOURNAL; PROTEIN EXPRESSION; RABIES VIRUS; SPINACH; VIRUS NEUTRALIZATION; VIRUS RECOMBINANT; ANIMAL; BIOSYNTHESIS; C3H MOUSE; DEFECTIVE VIRUS; EVALUATION; FOOD; GENETICS; IMMUNOLOGY; ISOLATION AND PURIFICATION; METABOLISM; METHODOLOGY; MOUSE; ORAL DRUG ADMINISTRATION; PHYSIOLOGY; SERODIAGNOSIS; SPECIES DIFFERENCE; TOBACCO; TOBACCO MOSAIC VIRUS; TRANSGENIC PLANT; VACCINATION;

ADMINISTRATION, ORAL; ALFALFA MOSAIC VIRUS; ANIMAL; ANTIBODIES, VIRAL; CAPSID PROTEINS; CHIMERIC PROTEINS; DEFECTIVE VIRUSES; FOOD; GLYCOPROTEINS; HUMAN; MICE; MICE, INBRED C3H; NEUTRALIZATION TESTS; NUCLEOPROTEINS; PLANT LEAVES; PLANTS, GENETICALLY MODIFIED; RABIES VACCINES; RABIES VIRUS; RECOMBINANT FUSION PROTEINS; SPECIES SPECIFICITY; SPINACH; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, NON-P.H.S.; TOBACCO; TOBACCO MOSAIC VIRUS; VACCINATION; VACCINES, SUBUNIT; VACCINES, SYNTHETIC; VIRAL PROTEINS; ANIMALS; HUMANS; SPINACIA OLERACEA;

EID: 0037135676     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0264-410X(02)00260-8     Document Type: Article

References (36)

1. Rationale and prospects for rabies elimination in developing countries
2. Oral immunization and protection of raccoons (Procyon lotor) with a vaccinia-rabies glycoprotein recombinant virus vaccine
3. Rabies
4. Predicting the local dynamics of epizootic rabies among raccoons in the United States
5. Rabies virus glycoprotein. Part II. Biological and serological characterization
6. Immunization of monkeys with rabies ribonucleoprotein (RNP) confers protective immunity against rabies
7. Antigenic analysis of rabies and Mokola virus from Zimbabwe using monoclonal antibodies
8. Oral vaccination of raccoons (Procyon lotor) with baculovirus-expressed rabies virus glycoprotein
9. Consideration of inactivated rabies vaccines as oral immunogens of wild carnivores
10. Rabies nucleocapsid as an oral immunogen and immunological enhancer
11. Structural and immunological characterization of a linear virus-neutralizing epitope of the rabies virus glycoprotein and its possible use in a synthetic vaccine
12. A new tobacco mosaic virus vector and its use for the systemic production of angiotensin-I-converting enzyme inhibitor in transgenic tobacco and tomato
13. Expression of an animal virus antigenic site on the surface of a plant virus particle
14. Development of cowpea mosaic virus as a high-yielding system for the presentation of foreign peptides
15. Plant virus expressing hybrid coat protein with added murine epitope elicits autoantibody response
16. Human immunodeficiency virus type 1-neutralizing antibodies raised to a glycoprotein 41 peptide expressed on the surface of a plant virus
17. Malarial epitopes expressed on the surface of recombinant tobacco mosaic virus
18. Antigens produced in plants by infection with chimeric plant viruses immunize against rabies virus and HIV-1
19. Immunization against rabies with plant-derived antigen
20. Plant-derived vaccine protects target animals against viral disease
21. Human respiratory syncytial virus vaccine antigen produced in plants
22. The coat protein alfalfa mosaic virus supports the long distance movement of TMV deficient in production of TMV coat protein
23. New developments in the pre- and post-exposure treatment of rabies
24. N-terminal basic amino acids of alfalfa mosaic virus coat protein involved in the initiation of infection
25. Replication of incomplete alfalfa mosaic virus genome in plants transformed with viral replicase genes
26. A rapid fluorescent focus inhibition test (RFFIT) for determining rabies virus-neutralizing antibody
27. Expression of hepatitis B surface antigen in transgenic plants
28. Oral immunization with a recombinant bacterial antigen produced in transgenic plants
29. Expression of the rabies virus glycoprotein in transgenic tomatoes
30. Expression of Norwalk virus capsid protein in transgenic tobacco and potato and its oral immunogenicity in mice
31. Production of antibodies in transgenic plants
32. Generation and assembly of secretory antibodies in plants
33. A plant derived edible vaccine against hepatitis B virus
34. Immunogenicity in humans of a recombinant bacterial antigen delivered in a transgenic potato
35. Human immune responses to a novel Norwalk virus vaccine delivered in transgenic potatoes